Buchumschlag

Efficacy of different spinal cord stimulation paradigms for the treatment of chronic neuropathic pain (PARS-trial): study protocol for a double-blinded, randomized, and placebo-controlled crossover trial

Spinal cord stimulation (SCS) is an effective method to treat neuropathic pain; however, it is challenging to compare different stimulation modalities in an individual patient, and thus, it is largely unknown which of the many available SCS modalities is most effective. Specifically, electrodes lead...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ahmadi, Rezvan (VerfasserIn) , Campos, Benito (VerfasserIn) , Hajiabadi, Mohammad Mehdi (VerfasserIn) , Dörr-Harim, Colette (VerfasserIn) , Tenckhoff, Solveig (VerfasserIn) , Rasche, Dirk (VerfasserIn) , Unterberg, Andreas (VerfasserIn) , Vesper, Jan (VerfasserIn) , Bruckner, Thomas (VerfasserIn) , Tronnier, Volker (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 25 January 2021
In: Trials
Year: 2021, Jahrgang: 22, Pages: 1-9
ISSN:1468-6694
DOI:10.1186/s13063-020-05013-7
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13063-020-05013-7
Verlag, kostenfrei, Volltext: https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-05013-7
Volltext
Verfasserangaben:Rezvan Ahmadi, Benito Campos, Mohammad Mehdi Hajiabadi, Colette Doerr-Harim, Solveig Tenckhoff, Dirk Rasche, Andreas Unterberg, Jan Vesper, Tom Bruckner and Volker Tronnier
Beschreibung
Zusammenfassung:Spinal cord stimulation (SCS) is an effective method to treat neuropathic pain; however, it is challenging to compare different stimulation modalities in an individual patient, and thus, it is largely unknown which of the many available SCS modalities is most effective. Specifically, electrodes leading out through the skin would have to be consecutively connected to different, incompatible SCS devices and be tested over a time period of several weeks or even months. The risk of wound infections for such a study would be unacceptably high and blinding of the trial difficult. The PARS-trial seizes the capacity of a new type of wireless SCS device, which enables a blinded and systematic intra-patient comparison of different SCS modalities over extended time periods and without increasing wound infection rates.
Beschreibung:Gesehen am 24.02.2021
Beschreibung:Online Resource
ISSN:1468-6694
DOI:10.1186/s13063-020-05013-7

Ähnliche Einträge